GROUP A STREPTOCOCCUS VACCINE
A vaccine for treating or preventing group A streptococcus streptococcus-associated diseases and conditions.
Vaccine to prevent group A streptococci infection
Vaccine - disease prevention
A method and composition for eliciting an immune response to group A streptococcal bacteria in a mammal is provided, which includes administering to the mammal an M protein fragment, variant or derivative thereof and a SpyCEP protein or peptide fragment, or an antibody to the SpyCEP protein or fragment to facilitate restoring or enhancing neutrophil activity. Also provided is an immunodominant peptide fragment of SpyCEP
Licensing
15/04/2015 00:00:00
MX/a/2016/013277
IL248266
MYPI2016001815
NZ725212
AU2015246654
SG11201608380P
US15/304462
BR1120160239156
JP2016/562764
EP15779482.7
CA2945052
IN201617038035
KR2016-7031477
IDP00201607493
墨西哥
